MAXCYTE, INC. Annual Operating Margin in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Maxcyte, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2023.
  • Maxcyte, Inc. Operating Margin for the quarter ending June 30, 2024 was -102 %, a 1.8% decline year-over-year.
  • Maxcyte, Inc. annual Operating Margin for 2023 was -117 %, a 89.2% decline from 2022.
  • Maxcyte, Inc. annual Operating Margin for 2022 was -61.8 %, a 15.2% decline from 2021.
  • Maxcyte, Inc. annual Operating Margin for 2021 was -53.7 %, a 27% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -117 -55.2 -89.2% Jan 1, 2023 Dec 31, 2023
2022 -61.8 -8.15 -15.2% Jan 1, 2022 Dec 31, 2022
2021 -53.7 -11.4 -27% Jan 1, 2021 Dec 31, 2021
2020 -42.3 +15.2 +26.4% Jan 1, 2020 Dec 31, 2020
2019 -57.4 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.